// App-Quantinova.ai

240 : Direct Oral Anticoagulants Reduce Hypercoagulopathy and Preserve Podocyte Function in an Experimental Model of Glomerular Disease

Researchers

Presenter

  • Amanda P. Waller

Principal Investigators

  • Katelyn J Wolfgang

  • Tasha K Wilkie

  • Sagar Bhayana

  • Bryce A. Kerlin

Medical Centers

  • The Research Institute at Nationwide Children's Hospital, Columbus, OH

  • Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH

  • Center for Clinical and Translational Research, The Research Institute at Nationwide Children’s Hospital, Department of Pediatrics, Division of Hematology/Oncology/BMT, The Ohio State University College of Medicine, Nationwide Children’s Hospital, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Urology

Disease

  • Chronic kidney disease

  • Glomerulonephritis

  • Podocyte injury

  • Renal disease

  • Albuminuria

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Evithrom

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved